Revonto Injection, Powder, Lyophilized, For Solution
Product Images NDC 84549-003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revonto (NDC 84549-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 003 67)

This text provides information about Revonto IV Solution, a prescription medication in 20mg/vial strength. It is an Injection USP in a 65mL Vial intended for Intravenous use only. The product must be protected from direct light and used within 6 hours after reconstitution. The unreconstituted product should be stored between 20°C to 25°C (68°F to 77°F). The text also includes manufacturer details, lot numbers, expiration dates, and packaging information. Additionally, it features a contact address in Westminster, CO for further inquiries.*

FDA Label Image

Chemical Structure (Revonto 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.